First-line checkpoint inhibitors in PD-L1-positive patients with advanced urothelial carcinoma
- PMID: 30457694
- DOI: 10.1111/bju.14627
First-line checkpoint inhibitors in PD-L1-positive patients with advanced urothelial carcinoma
Keywords: PD-L1 testing; atezolizumab; cisplatin-ineligible patients; pembrolizumab; urothelial carcinoma.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials